Investor Relations

Company Overview

Assembly Biosciences, Inc. (Nasdaq: ASMB) is a public biotechnology company advancing a new class of oral biologic drugs for addressing the gut microbiome and novel approaches to discovering drugs for the treatment of hepatitis B virus (HBV) infection.

Stock Quote

NASDAQ: ASMB
5.39
+ 0.02 (+0.37%)
2:39 PM ET on May 4, 2016
Delayed at least 20 minutes.

Stock Chart

Press Releases

Events & Presentations

Investor Contact

investors@assemblybio.com